Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,1552 USD | -1,18% | -11,96% | -14,67% |
Omzet 2022 | 25,9 mln. 24,32 mln. | Omzet 2023 | 42,81 mln. 40,2 mln. | Marktkapitalisatie | 17,99 mln. 16,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -33 mln. -30,99 mln. | Nettowinst (verlies) 2023 | -24 mln. -22,54 mln. | EV/omzet 2022 | 1,21 x |
Nettoliquiditeiten 2022 | 46,07 mln. 43,26 mln. | Nettoliquiditeiten 2023 | 26,37 mln. 24,76 mln. | EV/omzet 2023 | -0,2 x |
K/w-verhouding 2022 |
-2,32
x | K/w-verhouding 2023 |
-0,67
x | Werknemers | 48 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 92,57% |
Recentste transcriptie over Pieris Pharmaceuticals, Inc.
1 dag | -1,18% | ||
1 week | -11,96% | ||
Lopende maand | -15,23% | ||
1 maand | -26,05% | ||
3 maanden | -6,73% | ||
6 maanden | -41,02% | ||
Lopend jaar | -14,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 01-01-10 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 01-12-17 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 59 | 20-09-16 | |
James Geraghty
CHM | Chairman | 70 | 22-05-17 |
Michael Richman
BRD | Director/Board Member | 63 | 17-12-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,1552 | -1,18% | 664 507 |
17-04-24 | 0,1571 | -4,21% | 625 418 |
16-04-24 | 0,164 | -3,53% | 320 624 |
15-04-24 | 0,17 | -1,01% | 562 128 |
12-04-24 | 0,1717 | -2,65% | 233 222 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-14,67% | 15,36 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-1,57% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-8,68% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |